CRITICAL INNOVATIONS LLC — Department of Defense SBIR Phase I: A20-137
CRITICAL INNOVATIONS LLC — SBIR Phase I award from Department of Defense.
- Amount
- $167,500
- Agency
- Department of Defense · Army
- Program / Phase
- SBIR · Phase I
- Topic
- A20-137
- Solicitation
- 20.2
- NAICS
- —
- Place of performance
- CA
- Period
- 2020-10-08 → 2022-03-28
Description
The Army seeks to develop a technology that prevents infected and traumatized combat wounds on service members from becoming septic during extended tactical operations in austere environment. Critical Innovations and KARA & Associates, with consultants Captain David Tanen MD, FAAEM, FACMT (USN, Ret.) and former Commander Denise Whitfield, MD, FACEP (USN), have formed a team of medical device experts to address this important medical need. During this Phase I project, our objectives will be to further advance the innovative Succor™ Combat Foam for Advanced Wound Care of Traumatized Tissue with Infection. This will include: 1) On-boarding program requirements, goals, and schedule; 2) Development of proof-of-concept Succor™ prototype; 3) Performing Comparative Laboratory Testing on Selected Formulations; and, 6) Maintaining all regulatory compliance requirements and prepare for upcoming regulatory and transition hurdles.